Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allectus Capital is a private investment company and venture capital investor focused on disruptive technology businesses rather than a drug-development operating company. The firm invests across listed and unlisted companies, with reported exposure to sectors such as fintech, deep tech, and selected health or healthtech investments. Allectus appears to be managed in association with ICM and has been described as jointly owned by affiliated investment entities including UIL-related interests. Because it is an investor rather than a biotech developer, it does not appear to operate a therapeutic pipeline, clinical programs, or proprietary healthcare platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allectus Capital.